ALKBH5 and non-small cell lung carcinoma: ALKBH5-mediated reduction of RNA m6A levels can stabilize a variety of oncogenic drivers including UBE2C, SOX2 and MYC, thus promoting proliferation and invasion of NSCLC cells (Zhang et al., 2021).